Scope of this summary
Children younger than 24 months with an uncomplicated clinical syndrome of viral bronchiolitis. The operational source is Nationwide Children鈥檚 February 2026 institutional pathway, supported by CDC鈥檚 current RSV overview. Critical illness, apnea, congenital heart disease, chronic lung or neuromuscular disease, immune deficiency, suspected bacterial infection and an uncertain diagnosis require individualized pathways rather than automatic use of the uncomplicated branch.
The Bottom Line
- Diagnose typical bronchiolitis clinically from age, viral prodrome, cough, tachypnea, crackles or wheeze and feeding difficulty; routine chest radiography, broad laboratory panels and viral testing do not improve most uncomplicated care unless a result will change management or infection control.
- Prioritize gentle nasal suction when secretions interfere with breathing or feeding, hydration support, positioning, minimal handling and oxygen or respiratory support according to the child鈥檚 sustained physiology and the local pathway.
- Do not routinely use antibiotics, systemic corticosteroids or bronchodilators for a clear first episode of uncomplicated bronchiolitis. Reconsider asthma, bacterial pneumonia or another diagnosis when an atypical child appears to benefit from a diagnosis-specific treatment.
- Risk is higher with very young age, prematurity and important cardiopulmonary, neuromuscular or immune comorbidity; use a lower threshold for observation or admission when these factors combine with work of breathing or poor intake.
- Make disposition from repeated assessment of respiratory effort, oxygenation, apnea risk, feeding and hydration, caregiver ability and access to follow-up rather than from one post-suction observation.
Practical clinical workflow
1
Record age, gestation, symptom day, apnea or cyanosis, feeding and wet diapers, prior wheeze, atopy, smoke exposure and cardiopulmonary or neuromuscular disease; check current RSV prevention history only when it changes future preventive planning.
2
Observe respiratory rate and effort before disturbing the child, then assess air entry, crackles or wheeze, color, alertness, hydration and sustained pulse oximetry when clinically indicated.
3
Suction the nose and reassess feeding and work of breathing; offer small frequent feeds or enteral or intravenous hydration when oral intake is unsafe or inadequate, following the institution鈥檚 fluid protocol.
4
Escalate oxygen and respiratory support through the local bronchiolitis pathway when hypoxemia or fatigue persists, and involve critical care for apnea, rising support, poor air movement or impending respiratory failure.
5
At discharge, explain the expected illness course, suction and hydration strategies, smoke avoidance and precise return signs, and arrange timely review for younger or higher-risk infants.
Safety boundaries and escalation
- Apnea, cyanosis, exhaustion, altered responsiveness, severe retractions, grunting, poor air movement or rapidly rising oxygen requirement requires emergency respiratory support and senior review.
- Dehydration, aspiration risk or inability to coordinate feeding with breathing requires supervised hydration; do not force oral intake in a child with marked respiratory distress.
- Focal lung findings, persistent high fever, toxic appearance, a first wheezing episode outside the typical age range or sudden onset should prompt reassessment for pneumonia, sepsis, asthma, foreign body, cardiac disease or another cause.
- A transient pulse-oximeter reading should be checked against waveform and the child鈥檚 state; equally, reassuring saturation does not cancel severe work of breathing or apnea risk.
Localization
No current national US bronchiolitis guideline was identified that supersedes all local pathways; the older AAP guideline was not used as current claim evidence. Nationwide Children鈥檚 pathway is explicitly an institutional implementation example, while CDC supplies national RSV context. Admission thresholds, oxygen targets, testing and escalation devices must follow the treating institution and patient risk profile.
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Nationwide Children's HospitalBronchiolitis Clinical PathwayPublished 2016; last revised February 20, 2026 路 updated 2026-02-20 路 accessed 2026-08-20view source
- Centers for Disease Control and PreventionClinical Overview of RSVupdated 2025-08-18 路 accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.